Progress in antiviral drug and vaccine development assessed at international AIDS conference.
Miller
J L
JL
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D012254:Ribavirin / Q000627:therapeutic use; D013936:Thymidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014765:Viral Vaccines / Q000627:therapeutic use*; D016047:Zalcitabine; D015215:Zidovudine
D000998:Antiviral Agents; D014765:Viral Vaccines; D003841:Deoxycytidine; D012254:Ribavirin; D015215:Zidovudine; D016047:Zalcitabine; D013936:Thymidine